Study design and ethical considerations
Cerebral Palsy
CEREBRAL PALSY
This study was planned in the Department of Physiotherapy and Rehabilitation at Marmara University in Türkiye and implemented in the Family Counseling Center of Cerebral Palsy Türkiye. The design of this study was a stratified parallel‐randomized controlled study. The National Clinical Trial number is NCT04203589. tThe experimental group received the Explorer Baby early intervention program, and the active control group received NDT. Both groups received standard care in the country where the study was conducted. The assessors were blinded to the group assignment, but because of the nature of the study, practitioners and parents could not be blinded. The study's ethical approval was obtained from the Ethics Committee of Medicine Faculty of Marmara University (09.2017.729). Primary caregivers were informed, and their verbal and written consents were obtained before the initial assessment.